Duxin Sun

This inventor holds 28 USPTO granted patents and 14 published patent applications and 7 EPO patents, primarily in Nanoparticle Therapeutics. Top assignees: University of Michigan, Imra of America, Inc., Kura Oncology, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Duxin Sun. Retrieved from https://idiyas.com/inventor/duxin-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 14)

% Patents Active = 71.4

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 6.2

ph-index = 8

Forward Citations = 188(Granted Patents)

Company Filing History:

27 out of 3,525

University of Michigan

patents

2 out of 2

Imra of America, Inc.

4. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Nanoparticle Compositions

BET Inhibitors

Photothermal Therapy

MRI Applications

Gold Nanoparticles

Thienopyrimidine Compounds

Drug Delivery Systems

Core-Satellite Nanocomposites

Antigenic Peptides

Gastric-Intestinal Diseases

Spiro-Oxindole Antagonists

Glucosylceramide Synthase Inhibitors

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649001 - COMPLEXES FOR DELIVERY OF ANTIGENIC PEPTIDES (2026-06-09),

2. 12516080 - Remdesivir and remdesivir analogs, solutions, and nanoparticle, liposomal, and microparticle compositions for treating viral infections (2026-01-06),

3. 12226491 - Nano-satellite complexes (2025-02-18),

4. RE49687 - Thienopyrimidine and thienopyridine compounds and methods of use thereof (2023-10-10),

5. 11701433 - Complexes for delivery of antigenic peptides (2023-07-18),

6. 11647959 - Sampling device for drug development and diagnosis of gastric-intestinal diseases (2023-05-16),

7. 10898595 - Core-satellite nanocomposites for MRI and photothermal therapy (2021-01-26),

8. 10485886 - Core-satellite nanocomposites for MRI and photothermal therapy (2019-11-26),

9. 10391175 - BET bromodomain inhibitors and therapeutic methods using the same (2019-08-27),

10. 10253044 - 9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors (2019-04-09),

11. 10246464 - Thienopyrimidine and thienopyridine compounds and methods of use thereof (2019-04-02),

12. 10202340 - Glucosylceramide synthase inhibitors and therapeutic methods using the same (2019-02-12),

13. 10160769 - Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof (2018-12-25),

14. 9844347 - Electromagnetic system and method (2017-12-19),

15. 9675697 - BET bromodomain inhibitors and therapeutic methods using the same (2017-06-13),

Title: Inventor Duxin Sun: Revolutionizing Technology in Ann Arbor

Introduction: Duxin Sun is a pioneering inventor based in Ann Arbor, MI, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Duxin Sun holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Duxin Sun has worked with leading tech companies and research institutions, playing a key role in developing cutting-edge solutions that have transformed industries.

Collaborations: Throughout his career, Duxin Sun has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and excellence in all his projects.

Conclusion: Duxin Sun's relentless pursuit of innovation and his passion for creating a better future through technology make him a standout figure in the world of inventors and innovators.

Profile summary based on public USPTO records.